Livonia Partners invests in Medicum to support the acquisition of Fertilitas
Livonia invests in Medicum to support its acquisition of Fertilitas, strengthening its position as a leading private healthcare provider. Following the transaction, the Medicum team will grow to over 700 professionals. Together, the organisations will enhance integrated care pathways and further develop innovative treatment solutions across 18 medical specialities.
According to Maarja Pärs, Investment Director at Livonia Partners, the core shareholder of Medicum Group, strong and investment-capable organisations are playing an increasingly important role in the development of the healthcare sector: "In the long term, those private healthcare providers that can invest in development, their teams and quality will remain sustainable. A strong private healthcare sector offers patients increasingly better choices and is an important part of the overall healthcare system," said Maarja Pärs.
The transaction will enter into force following approval by the Competition Authority. The transaction is co-financed by SEB. The details of the transaction will not be disclosed by agreement between the parties.
For more information, please visit Medicum's homepage.
Newer
There are no newer news
